SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 2, 2003
MICROTEK MEDICAL HOLDINGS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Georgia
(State or Other Jurisdiction of Incorporation)
0-24866 | 58-1746149 |
(Commission File Number) | (I.R.S. Employer Identification No.) |
| |
512 Lehmberg Road; Columbus, Mississippi | 39702 |
(Address of Principal Executive Offices) | (Zip Code) |
(662) 327-1863
(Registrant’s Telephone Number, Including Area Code)
Item 9. Regulation FD Disclosure (Including Item 12 Information)
| On October 2, 2003, Microtek Medical Holdings, Inc. (the “Company”) issued a press release announcing its anticipated net revenues for the quarter and nine-month period ended September 30, 2003. This press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference. |
| Exhibits: |
| |
99.1 | Press release dated October 2, 2003, announcing the Company's anticipated net revenues for the quarter and nine-month period ended September 30, 2003 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be duly signed on its behalf by the undersigned hereunto duly authorized.
| MICROTEK MEDICAL HOLDINGS, INC. |
| |
| By:/s/ Dan R. Lee |
| Dan R. Lee, Chairman, President and Chief Executive Officer |
| |
| By:/s/ Roger G. Wilson |
| Roger G. Wilson, Chief Financial Officer |
Dated: October 2, 2003